These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 156587)

  • 21. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic significance of nonspecific suppressor cells in spleens of tumor-bearing mice.
    Hanna N; Kripke ML
    Cell Immunol; 1979 Mar; 43(2):293-303. PubMed ID: 314343
    [No Abstract]   [Full Text] [Related]  

  • 23. Mixed lymphocyte reactivity in spleen cells from F-9 tumor-bearing ice. I. Suppressor cell induction and characterization.
    Bluestone JA; Lopez C; Hurtenbach U
    Cell Immunol; 1981 Aug; 62(2):334-40. PubMed ID: 6456820
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ; Seeger RC
    Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressor T cells in tumor bearing host.
    Fujimoto S; Greene M; Sehon AH
    Immunol Commun; 1975; 4(3):201-17. PubMed ID: 1080741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.
    Farrar WL; Elgert KD
    Int J Cancer; 1978 Aug; 22(2):142-51. PubMed ID: 308934
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ; Conroy JM; Elgert KD
    Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis.
    Roszman TL; Cross RJ; Brooks WH; Markesbery WR
    Immunology; 1982 Apr; 45(4):737-42. PubMed ID: 6461593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between T cells and non-T cells in suppression of cytotoxic lymphocyte responses.
    Truitt GA; Dennison DK; Rich RR; Rich SS
    J Immunol; 1979 Aug; 123(2):745-50. PubMed ID: 156762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune depression in trypanosome-infected mice. III. suppressor cells.
    Pearson TW; Roelants GE; Pinder M; Lundin LB; Mayor-Withey KS
    Eur J Immunol; 1979 Mar; 9(3):200-4. PubMed ID: 156120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell interactions in the induction of lymphocyte proliferative responses: requirement of macrophages and aFcR gamma + T lymphocytes in the induction of aFcR gamma - lymphocyte proliferation.
    Bykowsky MJ; Stout RD
    J Immunol; 1983 May; 130(5):2093-8. PubMed ID: 6220080
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of immune responses by suppressor T cells.
    Pierce CW; Kapp JA
    Tohoku J Exp Med; 1976; 5():91-143. PubMed ID: 61102
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction.
    Feldmann M; Kontiainen S
    Eur J Immunol; 1976 Apr; 6(4):302-5. PubMed ID: 1086779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 37. Properties of reticulum cell sarcomas in SJL/J mice. VII. Nature of normal lymphoid cells proliferating in response to tumor cells.
    Lerman SP; Chapman-Alexander J; Umetsu D; Thorbecke GJ
    Cell Immunol; 1979 Mar; 43(1):209-13. PubMed ID: 380818
    [No Abstract]   [Full Text] [Related]  

  • 38. T lymphocytes with promiscuous cytotoxicity.
    Shustik C; Cohen IR; Schwartz RS; Latham-Griffin E; Waksal SD
    Nature; 1976 Oct; 263(5579):699-701. PubMed ID: 1086436
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.